News9 months ago
Achilles Therapeutics Reports Q1 2024 Financial Results and Recent Business Highlights
Achilles Therapeutics PLC – Provided interim Phase I/IIa update on clonal neoantigen-reactive T cells in advanced NSCLC and melanoma – – Evaluating the benefit of improved...